Combination treatment with cobimetinib (C) and atezolizumab (A) vs pembrolizumab (P) in previously untreated patients (pts) with BRAFV600 wild type (wt) advanced melanoma: Primary analysis from the phase III IMspire170 trial

Ana Arance, Helen Gogas, Brigitte Dréno, Keith T. Flaherty, Lev Demidov, Daniil Stroyakovskiy, Zeynep Eroglu, Pier Francesco Ferrucci, Jacopo Pigozzo, Piotr Rutkowski,

Annals of Oncology · 2019 · 29 citations · 0 references

Concepts